Monash IVF Group ROCE 2024

Monash IVF Group ROCE

0.12

Monash IVF Group Dividend yield

4.41 %

Ticker

MVF.AX

ISIN

AU000000MVF3

WKN

A116LZ

In 2024, Monash IVF Group's return on capital employed (ROCE) was 0.12, a 14.48% increase from the 0.11 ROCE in the previous year.

Monash IVF Group Aktienanalyse

What does Monash IVF Group do?

The Monash IVF Group Ltd is a company in Australia specializing in reproductive medicine. It was founded in 1970 by Professor Gab Kovacs, who is considered one of the pioneers in the field of in-vitro fertilization (IVF). The company's history began in a small laboratory in Melbourne, where the first successful IVF procedures were performed. Over time, Monash IVF grew and expanded its focus to include other reproductive treatments such as donor egg programs, sperm donation, and cryopreservation. Monash IVF Group Ltd has since become a leading provider in Australia, with 19 clinics throughout the country. The company is not only active in Australia but also operates clinics in Malaysia and Vietnam. The business model of Monash IVF Group Ltd is centered around helping couples and individuals fulfill their desire to have children. The company offers a wide range of treatments tailored to the individual needs and circumstances of each patient. Among the services offered are not only IVF, donor egg programs, and sperm donation but also other technologies such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). Monash IVF Group Ltd sees itself as an all-rounder and therefore also offers psychological support and guidance during and after treatments. One of the company's specialties is its comprehensive research work. The Monash IVF Group has a specialized research department actively involved in researching new reproductive technologies. The company collaborates closely with universities and leading scientific institutes to gain the latest insights in this field and achieve the best possible outcomes for its patients. Monash IVF Group Ltd is divided into various divisions, each with different focuses and offerings. The main division is the Monash IVF Clinic, specializing in reproductive health and fertility. Here, all common IVF and fertility treatments are offered. Another division is Monash IVF Fertility Diagnostics, specializing in diagnostics and screening of fertility and reproductive problems. State-of-the-art diagnostic procedures for evaluating male and female fertility are used here. Monash IVF Genomics is another division offering genetic counseling, screening, and diagnostics. Here, couples can determine their genetic risk factors for fertility problems and receive support in making the best possible decisions regarding family planning. In addition to these divisions, Monash IVF Group Ltd also offers specialized services. For example, there is the Monash IVF Donor Program, specializing in the facilitation of anonymous and open donor programs. The Monash IVF DNA Matching can also assist in the search for genetic relatives by utilizing advanced DNA profiling. As a leading company in the field of fertility, Monash IVF Group Ltd offers a wide range of products and services to help couples and individuals fulfill their desire to have children. With a long history of innovation and research, as well as a variety of divisions and offerings, the company is an important provider of reproductive medicine in Australia and beyond. Monash IVF Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Monash IVF Group's Return on Capital Employed (ROCE)

Monash IVF Group's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Monash IVF Group's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Monash IVF Group's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Monash IVF Group’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Monash IVF Group Stock

What is the ROCE (Return on Capital Employed) of Monash IVF Group this year?

The ROCE of Monash IVF Group is 0.12 undefined this year.

How has the ROCE (Return on Capital Employed) of Monash IVF Group developed compared to the previous year?

The ROCE of Monash IVF Group has increased by 14.48% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Monash IVF Group?

A high Return on Capital Employed (ROCE) indicates that Monash IVF Group has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Monash IVF Group?

A low ROCE (Return on Capital Employed) can indicate that Monash IVF Group has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Monash IVF Group impact the company?

An increase in the ROCE of Monash IVF Group can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Monash IVF Group affect the company?

A decrease in ROCE of Monash IVF Group can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Monash IVF Group?

Some factors that can affect Monash IVF Group's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Monash IVF Group so important for investors?

The ROCE of Monash IVF Group is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Monash IVF Group take to improve the ROCE?

To improve the ROCE, Monash IVF Group can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Monash IVF Group pay?

Over the past 12 months, Monash IVF Group paid a dividend of 0.06 AUD . This corresponds to a dividend yield of about 4.41 %. For the coming 12 months, Monash IVF Group is expected to pay a dividend of 0.06 AUD.

What is the dividend yield of Monash IVF Group?

The current dividend yield of Monash IVF Group is 4.41 %.

When does Monash IVF Group pay dividends?

Monash IVF Group pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Monash IVF Group?

Monash IVF Group paid dividends every year for the past 13 years.

What is the dividend of Monash IVF Group?

For the upcoming 12 months, dividends amounting to 0.06 AUD are expected. This corresponds to a dividend yield of 4.37 %.

In which sector is Monash IVF Group located?

Monash IVF Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Monash IVF Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Monash IVF Group from 4/5/2024 amounting to 0.036 AUD, you needed to have the stock in your portfolio before the ex-date on 3/7/2024.

When did Monash IVF Group pay the last dividend?

The last dividend was paid out on 4/5/2024.

What was the dividend of Monash IVF Group in the year 2023?

In the year 2023, Monash IVF Group distributed 0.063 AUD as dividends.

In which currency does Monash IVF Group pay out the dividend?

The dividends of Monash IVF Group are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Monash IVF Group

Our stock analysis for Monash IVF Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Monash IVF Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.